Analysis of prognostic factors and pharmacodynamic parameters in relapsed indolent B-NHL and mantle cell lymphoma (MCL) treated with rituximab.

被引：0
|
作者：
Tobinai, K
Igarashi, T
Ogura, M
Kinoshita, T
Kobayashi, Y
Sasaki, Y
Morishima, Y
Uike, N
Taniwaki, M
Kano, Y
Kasai, M
Ohnishi, K
机构：
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4808
引用
收藏
页码：249B / 249B
页数：1
相关论文
共 50 条
  • [1] A multicenter phase II study of vorinostat in patients (pts) with relapsed or refractory indolent B-cell non-Hodgkin lymphoma (B-NHL) or mantle cell lymphoma (MCL).
    Ando, Kiyoshi
    Ogura, Michinori
    Suzuki, Tatsuya
    Ishizawa, Kenichi
    Oh, Sung Yong
    Kim, Won Seog
    Tanaka, Yoshinobu
    Shimamoto, Takashi
    Tobinai, Kensei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Bendamustine Is Highly Effective for Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphoma (B-NHL) and Mantle Cell Lymphoma (MCL): Final Results of a Japanese Multicenter Phase II Study.
    Ogura, Michinori
    Uchida, Toshiki
    Ando, Kiyoshi
    Ohmachi, Ken
    Itoh, Kuniaki
    Kubota, Nobuko
    Ishizawa, Kenichi
    Yamamoto, Joji
    Watanabe, Takashi
    Uike, Naokuni
    Choi, Ilseung
    Terui, Yasuhito
    Usuki, Kensuke
    Nagai, Hirokazu
    Uoshima, Nobuhiko
    Tobinai, Kensei
    [J]. BLOOD, 2009, 114 (22) : 1422 - 1422
  • [3] Phase II Trial of Lenalidomide - Dexamethasone - Rituximab in Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab.
    Ahmadi, Tahamtan
    Chong, Elise A.
    Gordon, Amanda
    Aqui, Nicole A.
    Downs, Lisa H.
    Leinbach, Leah
    Goldstein, Steven C.
    Nasta, Sunita D.
    Janofsky, Stephen
    Maniar, Tapan N.
    Svoboda, Jakub
    Schuster, Stephen J.
    [J]. BLOOD, 2009, 114 (22) : 677 - 677
  • [4] IBRITUMOMAB TIUXETAN (ZEVALIN®) IS HIGHLY EFFECTIVE IN FIRST RELAPSED INDOLENT B CELL NON-HODGKIN LYMPHOMA (B-NHL)
    Uchida, Toshiki
    Suzuki, Tatsuya
    Oyama, Takashi
    Okamoto, Akinao
    Kasai, Masanobu
    Ikeda, Mika
    Nanbu, Ichiro
    Nakamura, Masashi
    Imamura, Shin
    Ogura, Michinori
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 39 - 39
  • [5] Rituximab as in vivo purging agent in autologous stem cell transplantation for relapsed B-NHL
    Hess, G
    Flohr, T
    Derigs, HG
    [J]. ANNALS OF HEMATOLOGY, 2002, 81 : S54 - S55
  • [6] Flavopiridol, fludarabine and rituximab (FFR) is an active regimen in indolent B-cell lymphoproliferative disorders and mantle cell lymphoma (MCL).
    Lin, T. S.
    Fischer, B.
    Moran, M. E.
    Shank, R. S.
    Kraut, E.
    Porcu, P.
    Farag, S. S.
    Blum, K. A.
    Colevas, A. D.
    Grever, M. R.
    Byrd, J. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 446S - 446S
  • [7] Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study
    Igarashi, T
    Kobayashi, Y
    Ogura, M
    Kinoshita, T
    Ohtsu, T
    Sasaki, Y
    Morishima, Y
    Murate, T
    Kasai, M
    Uike, N
    Taniwaki, M
    Kano, Y
    Ohnishi, K
    Matsuno, Y
    Nakamura, S
    Mori, S
    Ohashi, Y
    Tobinai, K
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (06) : 928 - 943
  • [8] Phase II study of oral Fludarabine (FAMP) in combination with rituximab in indolent B-cell non-hodgkin lymphoma (B-NHL)
    Ishizawa, Kenichi
    Tobinai, Kensei
    Ogura, Michinori
    Itoh, Kuniaki
    Aorishima, Yasuo
    Ando, Kiyoshi
    Yamamoto, Joji
    Watanabe, Takashi
    Uchida, Toshiki
    Nakata, Masanobu
    Hayashi, Masaki
    Hotta, Tomomitsu
    [J]. BLOOD, 2007, 110 (11) : 387A - 387A
  • [9] THE ROLE OF MANTLE CELL INTERNATIONAL PROGNOSTIC INDEX (MIPI) AS SURVIVAL PREDICTOR IN MANTLE CELL LYMPHOMA (MCL) PATIENTS TREATED WITH RITUXIMAB AND CHEMOTHERAPY
    Chiappella, A.
    Puccini, B.
    Rossi, M.
    Arcaini, L.
    Audisio, E.
    Baldi, I.
    Benevolo, G.
    Boccomini, C.
    Botto, B.
    Ciochetto, C.
    Fabbri, F.
    Ferrero, S.
    Frairia, C.
    Freilone, R.
    Ladetto, M.
    Novero, D.
    Paulli, M.
    Pregno, P.
    Priolo, G.
    Rigacci, L.
    Vitolo, U.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 114 - 114
  • [10] Primary cutaneous large B cell lymphoma of the legs treated with rituximab.
    Aboulafia, DM
    [J]. BLOOD, 1999, 94 (10) : 257B - 257B
12345